299 related articles for article (PubMed ID: 14870533)
1. [A case of intraductal multicentric breast carcinoma with bilateral axillary metastases].
Vidu V; Hortopan M; Aldea C; Liscu B; Popovici A
Chirurgia (Bucur); 2000; 95(6):543-7. PubMed ID: 14870533
[TBL] [Abstract][Full Text] [Related]
2. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
Huston TL; Pressman PI; Moore A; Vahdat L; Hoda SA; Kato M; Weinstein D; Tousimis E
Breast J; 2007; 13(2):158-64. PubMed ID: 17319857
[TBL] [Abstract][Full Text] [Related]
3. The role of sentinel lymph node biopsy in the management of breast cancer.
Khan A; Vohra P; Quinlan RF
Indian J Pathol Microbiol; 2007 Apr; 50(2):261-9. PubMed ID: 17883042
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
5. Bilateral axillary metastases of occult breast carcinoma: report of a case with a review of the literature.
Steunebrink M; Schnater JM; Storm RK; van Ingen G; Vegt PA; Plaisier PW
Breast; 2005 Apr; 14(2):165-8. PubMed ID: 15767189
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of breast cancer. A retrospective study of 569 cases in clinical stages I-III.
Nikkanen TA
Acta Chir Scand; 1981; 147(4):239-45. PubMed ID: 6275648
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in young women: case report and a review.
Batori M; Ruggieri M; Chatelou E; Straniero A; Mariotta G; Palombi L; Casella G; Basile M; Casella MC
Eur Rev Med Pharmacol Sci; 2006; 10(2):51-2. PubMed ID: 16705948
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
10. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
11. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
12. Papillary carcinoma arising from ectopic breast tissue in an axillary lymph node.
Walker AN; Fechner RE
Diagn Gynecol Obstet; 1982; 4(2):141-5. PubMed ID: 6284467
[TBL] [Abstract][Full Text] [Related]
13. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
15. Axillary recurrence in DCIs: is axillary lymphadenectomy warranted?
Trisal V; Qian D; Wagman LD
Am Surg; 2004 Oct; 70(10):876-80. PubMed ID: 15529841
[TBL] [Abstract][Full Text] [Related]
16. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
17. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature.
Guth AA; Mercado C; Roses DF; Darvishian F; Singh B; Cangiarella JF
Breast J; 2008; 14(4):335-9. PubMed ID: 18537917
[TBL] [Abstract][Full Text] [Related]
18. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and patho-anatomic aspects of metastases of breast cancer].
Heberling D; Höffken H; Kühn W; Leppien G; Rieth J; Rummel HH; Tshahagane C
Geburtshilfe Frauenheilkd; 1984 Feb; 44(2):79-83. PubMed ID: 6329894
[TBL] [Abstract][Full Text] [Related]
20. EVOLUTION OF SYNCHRONOUS BILATERAL BREAST CARCINOMA IN A YOUNG PATIENT.
Manea E; Munteanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):192-6. PubMed ID: 27125095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
